€249,00
Il test rapido VivaDiag™ PRO SARS-CoV-2 Ag serve per il rilevamento rapido e qualitativo dell’antigene della proteina nucleocapside da SARS-CoV-2 in campioni di tampone nasale umano, tampone orofaringeo o tampone nasofaringeo. Tasso di corrispondenza VS RT-PCR: 98%
VivaDiag Pro SARS-CoV-2 Ag Rapid Test is for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in human nasal swab, oropharyngeal swab or nasopharyngeal swab specimen. The test is for in vitro diagnostic use only. VivaDiag Pro SARS-CoV-2 Ag Rapid Test is designed with enhanced sensitivity as 97.06%.
| VivaDiagTM Pro SARSCoV-2 Ag Rapid Test | PCR (CT value<30) | ||
| Positive | Negative | Total | |
| Positive | 99 | 0 | 99 |
| Negative | 3 | 431 | 434 |
| Total | 102 | 431 | 533 |
| Sensibilità | 97.06%
(99/102, 95%CI, 91.71%~98.99%) |
||
| Specificità | 100%
(431/431 95%CI, 99.12%~100%) |
||
| Attendibilità / Accuratezza | 99.44%
(530/533 95%CI, 98.36%~99.81%) |
||
The VivaDiag™ PRO SARS-CoV-2 Ag Test showed a clinical sensitivity of 97.06%.
The VivaDiag™ PRO SARS-CoV-2 Ag Test showed a clinical specificity of 100%.
The VivaDiag™ PRO SARS-CoV-2 Ag Test showed a clinical accuracy of 99.44%.
Test Parameters: SARS-CoV-2 Ag
Test Principle: Immunochromatorgraphy
Sample Type: Nasal swab / Nasopharyngeal swab / oropharyngeal swab
Sample Volume: 60 μl
Test Time: 15 min
Operation Temperature: 15-30°C
Storage Temperature: 2-30°C
Shelf Life: 24 months
